TY - JOUR AU - Lim, L. S. AU - Mitchell, P. AU - Seddon, J. M. AU - Holz, F. G. AU - Wong, T. Y. PY - 2012 DA - 2012// TI - Age-related macular degeneration JO - Lancet. VL - 379 UR - https://doi.org/10.1016/S0140-6736(12)60282-7 DO - 10.1016/S0140-6736(12)60282-7 ID - Lim2012 ER - TY - JOUR AU - Mitchell, P. AU - Liew, G. AU - Gopinath, B. AU - Wong, T. Y. PY - 2018 DA - 2018// TI - Age-related macular degeneration JO - Lancet. VL - 392 UR - https://doi.org/10.1016/S0140-6736(18)31550-2 DO - 10.1016/S0140-6736(18)31550-2 ID - Mitchell2018 ER - TY - JOUR AU - Pascolini, D. AU - Mariotti, S. P. PY - 2012 DA - 2012// TI - Global estimates of visual impairment: 2010 JO - Br J Ophthalmol VL - 96 UR - https://doi.org/10.1136/bjophthalmol-2011-300539 DO - 10.1136/bjophthalmol-2011-300539 ID - Pascolini2012 ER - TY - STD TI - Access Economics Pty Limited. The global economic cost of visual impairment for AMD Alliance International; 2010. Available athttp://www.icoph.org/dynamic/attachments/resources/globalcostofvi_finalreport.pdf. UR - http://www.icoph.org/dynamic/attachments/resources/globalcostofvi_finalreport.pdf ID - ref4 ER - TY - JOUR AU - Wong, W. L. AU - Su, X. AU - Li, X. AU - Cheung, C. M. AU - Klein, R. AU - Cheng, C. Y. PY - 2014 DA - 2014// TI - Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis JO - Lancet Glob Health VL - 2 UR - https://doi.org/10.1016/S2214-109X(13)70145-1 DO - 10.1016/S2214-109X(13)70145-1 ID - Wong2014 ER - TY - JOUR AU - Ferris, F. L. AU - Fine, S. L. AU - Hyman, L. PY - 1984 DA - 1984// TI - Age-related macular degeneration and blindness due to neovascular maculopathy JO - Arch Ophthalmol VL - 102 UR - https://doi.org/10.1001/archopht.1984.01040031330019 DO - 10.1001/archopht.1984.01040031330019 ID - Ferris1984 ER - TY - JOUR AU - Brown, D. M. AU - Kaiser, P. K. AU - Michels, M. AU - Soubrane, G. AU - Heier, J. S. AU - Kim, R. Y. PY - 2006 DA - 2006// TI - Ranibizumab versus verteporfin for neovascular age-related macular degeneration JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa062655 DO - 10.1056/NEJMoa062655 ID - Brown2006 ER - TY - JOUR AU - Heier, J. S. AU - Brown, D. M. AU - Chong, V. AU - Korobelnik, J. F. AU - Kaiser, P. K. AU - Nguyen, Q. D. PY - 2012 DA - 2012// TI - Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration JO - Ophthalmology. VL - 119 UR - https://doi.org/10.1016/j.ophtha.2012.09.006 DO - 10.1016/j.ophtha.2012.09.006 ID - Heier2012 ER - TY - JOUR AU - Rosenfeld, P. J. AU - Brown, D. M. AU - Heier, J. S. AU - Boyer, D. S. AU - Kaiser, P. K. AU - Chung, C. Y. PY - 2006 DA - 2006// TI - Ranibizumab for neovascular age-related macular degeneration JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa054481 DO - 10.1056/NEJMoa054481 ID - Rosenfeld2006 ER - TY - JOUR AU - Schmidt-Erfurth, U. AU - Kaiser, P. K. AU - Korobelnik, J. F. AU - Brown, D. M. AU - Chong, V. AU - Nguyen, Q. D. PY - 2014 DA - 2014// TI - Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies JO - Ophthalmology. VL - 121 UR - https://doi.org/10.1016/j.ophtha.2013.08.011 DO - 10.1016/j.ophtha.2013.08.011 ID - Schmidt-Erfurth2014 ER - TY - JOUR AU - Alexandru, M. R. AU - Alexandra, N. M. PY - 2016 DA - 2016// TI - Wet age related macular degeneration management and follow-up JO - Rom J Ophthalmol VL - 60 ID - Alexandru2016 ER - TY - JOUR AU - Bloch, S. B. AU - Larsen, M. AU - Munch, I. C. PY - 2012 DA - 2012// TI - Incidence of legal blindness from age-related macular degeneration in Denmark: year 2000 to 2010 JO - Am J Ophthalmol VL - 153 UR - https://doi.org/10.1016/j.ajo.2011.10.016 DO - 10.1016/j.ajo.2011.10.016 ID - Bloch2012 ER - TY - JOUR AU - Johnston, R. L. AU - Lee, A. Y. AU - Buckle, M. AU - Antcliff, R. AU - Bailey, C. AU - McKibbin, M. PY - 2016 DA - 2016// TI - UK age-related macular degeneration electronic medical record system (AMD EMR) users group report IV: incidence of blindness and sight impairment in Ranibizumab-treated patients JO - Ophthalmology. VL - 123 UR - https://doi.org/10.1016/j.ophtha.2016.07.037 DO - 10.1016/j.ophtha.2016.07.037 ID - Johnston2016 ER - TY - BOOK PY - 2006 DA - 2006// TI - Systematic Reviews: CRD’s Guidance for Undertaking Reviews in Health Care PB - University of York CY - York ID - ref14 ER - TY - JOUR AU - Borooah, S. AU - Jeganathan, V. S. AU - Ambrecht, A. M. AU - Oladiwura, D. AU - Gavin, M. AU - Dhillon, B. PY - 2015 DA - 2015// TI - Long-term visual outcomes of intravitreal ranibizumab treatment for wet age-related macular degeneration and effect on blindness rates in south-east Scotland JO - Eye (Lond) VL - 29 UR - https://doi.org/10.1038/eye.2015.83 DO - 10.1038/eye.2015.83 ID - Borooah2015 ER - TY - JOUR AU - Bressler, N. M. AU - Doan, Q. V. AU - Varma, R. AU - Lee, P. P. AU - Suner, I. J. AU - Dolan, C. PY - 2011 DA - 2011// TI - Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degeneration JO - Arch Ophthalmol VL - 129 UR - https://doi.org/10.1001/archophthalmol.2011.140 DO - 10.1001/archophthalmol.2011.140 ID - Bressler2011 ER - TY - JOUR AU - Campbell, J. P. AU - Bressler, S. B. AU - Bressler, N. M. PY - 2012 DA - 2012// TI - Impact of availability of anti-vascular endothelial growth factor therapy on visual impairment and blindness due to neovascular age-related macular degeneration JO - Arch Ophthalmol VL - 130 UR - https://doi.org/10.1001/archophthalmol.2011.2480 DO - 10.1001/archophthalmol.2011.2480 ID - Campbell2012 ER - TY - JOUR AU - Keenan, T. D. AU - Kelly, S. P. AU - Sallam, A. AU - Mohamed, Q. AU - Tufail, A. AU - Johnston, R. L. PY - 2013 DA - 2013// TI - Incidence and baseline clinical characteristics of treated neovascular age-related macular degeneration in a well-defined region of the UK JO - Br J Ophthalmol VL - 97 UR - https://doi.org/10.1136/bjophthalmol-2013-303233 DO - 10.1136/bjophthalmol-2013-303233 ID - Keenan2013 ER - TY - JOUR AU - Minassian, D. C. AU - Reidy, A. AU - Lightstone, A. AU - Desai, P. PY - 2011 DA - 2011// TI - Modelling the prevalence of age-related macular degeneration (2010-2020) in the UK: expected impact of anti-vascular endothelial growth factor (VEGF) therapy JO - Br J Ophthalmol VL - 95 UR - https://doi.org/10.1136/bjo.2010.195370 DO - 10.1136/bjo.2010.195370 ID - Minassian2011 ER - TY - JOUR AU - Mitchell, P. AU - Bressler, N. AU - Doan, Q. V. AU - Dolan, C. AU - Ferreira, A. AU - Osborne, A. PY - 2014 DA - 2014// TI - Estimated cases of blindness and visual impairment from neovascular age-related macular degeneration avoided in Australia by ranibizumab treatment JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0101072 DO - 10.1371/journal.pone.0101072 ID - Mitchell2014 ER - TY - JOUR AU - Rostron, E. AU - McKibbin, M. PY - 2012 DA - 2012// TI - Visual impairment certification secondary to ARMD in Leeds, 2005-2010: is the incidence falling? JO - Eye (Lond) VL - 26 UR - https://doi.org/10.1038/eye.2012.61 DO - 10.1038/eye.2012.61 ID - Rostron2012 ER - TY - JOUR AU - Skaat, A. AU - Chetrit, A. AU - Belkin, M. AU - Kinori, M. AU - Kalter-Leibovici, O. PY - 2012 DA - 2012// TI - Time trends in the incidence and causes of blindness in Israel JO - Am J Ophthalmol VL - 153 UR - https://doi.org/10.1016/j.ajo.2011.08.035 DO - 10.1016/j.ajo.2011.08.035 ID - Skaat2012 ER - TY - JOUR AU - Sloan, F. A. AU - Hanrahan, B. W. PY - 2014 DA - 2014// TI - The effects of technological advances on outcomes for elderly persons with exudative age-related macular degeneration JO - JAMA Ophthalmol VL - 132 UR - https://doi.org/10.1001/jamaophthalmol.2013.7647 DO - 10.1001/jamaophthalmol.2013.7647 ID - Sloan2014 ER - TY - JOUR AU - Moher, D. AU - Liberati, A. AU - Tetzlaff, J. AU - Altman, D. G. PY - 2009 DA - 2009// TI - Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement JO - PLoS Med VL - 6 UR - https://doi.org/10.1371/journal.pmed.1000097 DO - 10.1371/journal.pmed.1000097 ID - Moher2009 ER - TY - JOUR AU - Finger, R. P. AU - Guymer, R. H. AU - Gillies, M. C. AU - Keeffe, J. E. PY - 2014 DA - 2014// TI - The impact of anti-vascular endothelial growth factor treatment on quality of life in neovascular age-related macular degeneration JO - Ophthalmology. VL - 121 UR - https://doi.org/10.1016/j.ophtha.2013.12.032 DO - 10.1016/j.ophtha.2013.12.032 ID - Finger2014 ER - TY - JOUR AU - Finger, R. P. AU - Wiedemann, P. AU - Blumhagen, F. AU - Pohl, K. AU - Holz, F. G. PY - 2013 DA - 2013// TI - Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - a noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany JO - Acta Ophthalmol VL - 91 UR - https://doi.org/10.1111/j.1755-3768.2012.02493.x DO - 10.1111/j.1755-3768.2012.02493.x ID - Finger2013 ER - TY - JOUR AU - Inoue, M. AU - Arakawa, A. AU - Yamane, S. AU - Kadonosono, K. PY - 2014 DA - 2014// TI - Intravitreal injection of ranibizumab using a pro re nata regimen for age-related macular degeneration and vision-related quality of life JO - Clin Ophthalmol VL - 8 UR - https://doi.org/10.2147/OPTH.S68293 DO - 10.2147/OPTH.S68293 ID - Inoue2014 ER - TY - JOUR AU - Zhu, M. AU - Wijeyakumar, W. AU - Syed, A. R. AU - Joachim, N. AU - Hong, T. AU - Broadhead, G. K. PY - 2017 DA - 2017// TI - Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration JO - Graefes Arch Clin Exp Ophthalmol VL - 255 UR - https://doi.org/10.1007/s00417-016-3477-9 DO - 10.1007/s00417-016-3477-9 ID - Zhu2017 ER - TY - JOUR AU - Casten, R. AU - Rovner, B. W. AU - Leiby, B. E. AU - Tasman, W. PY - 2010 DA - 2010// TI - Depression despite anti-vascular endothelial growth factor treatment of age-related macular degeneration JO - Arch Ophthalmol VL - 128 UR - https://doi.org/10.1001/archophthalmol.2010.24 DO - 10.1001/archophthalmol.2010.24 ID - Casten2010 ER - TY - STD TI - Cooley S-SL. Doherty BE, Davidorf FH . Stress, depression, and changes in visual functioning with anti-VEGF treatment in patients with age-related macular degeneration (AMD). Invest Ophthalmol Vis Sci 2016;57:1969. ID - ref30 ER - TY - JOUR AU - Lee, W. J. AU - Cho, H. Y. AU - Kim, D. H. AU - Yu, H. G. AU - Oh, J. AU - Kim, J. S. PY - 2013 DA - 2013// TI - Depression of Late Age-Related Macular Degeneration Patients in Korea JO - Asia Pac J Ophthalmol (Phila) VL - 2 UR - https://doi.org/10.1097/APO.0b013e31827be8b1 DO - 10.1097/APO.0b013e31827be8b1 ID - Lee2013 ER - TY - JOUR AU - Segal, O. AU - Segal-Trivitz, Y. AU - Nemet, A. Y. AU - Cohen, P. AU - Geffen, N. AU - Mimouni, M. PY - 2016 DA - 2016// TI - Anxiety levels and perceived pain intensity during intravitreal injections JO - Acta Ophthalmol VL - 94 UR - https://doi.org/10.1111/aos.12802 DO - 10.1111/aos.12802 ID - Segal2016 ER - TY - JOUR AU - Senra, H. AU - Balaskas, K. AU - Mahmoodi, N. AU - Aslam, T. PY - 2017 DA - 2017// TI - Experience of anti-VEGF treatment and clinical levels of depression and anxiety in patients with wet age-related macular degeneration JO - Am J Ophthalmol VL - 177 UR - https://doi.org/10.1016/j.ajo.2017.03.005 DO - 10.1016/j.ajo.2017.03.005 ID - Senra2017 ER - TY - JOUR AU - Mangione, C. M. AU - Lee, P. P. AU - Gutierrez, P. R. AU - Spritzer, K. AU - Berry, S. AU - Hays, R. D. PY - 2001 DA - 2001// TI - Development of the 25-item National eye Institute visual function questionnaire JO - Arch Ophthalmol VL - 119 UR - https://doi.org/10.1001/archopht.119.7.1050 DO - 10.1001/archopht.119.7.1050 ID - Mangione2001 ER - TY - JOUR AU - Lamoureux, E. L. AU - Pallant, J. F. AU - Pesudovs, K. AU - Hassell, J. B. AU - Keeffe, J. E. PY - 2006 DA - 2006// TI - The impact of vision impairment questionnaire: an evaluation of its measurement properties using Rasch analysis JO - Invest Ophthalmol Vis Sci VL - 47 UR - https://doi.org/10.1167/iovs.06-0220 DO - 10.1167/iovs.06-0220 ID - Lamoureux2006 ER - TY - JOUR AU - Lamoureux, E. L. AU - Pallant, J. F. AU - Pesudovs, K. AU - Rees, G. AU - Hassell, J. B. AU - Keeffe, J. E. PY - 2007 DA - 2007// TI - The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and rasch analysis JO - Invest Ophthalmol Vis Sci VL - 48 UR - https://doi.org/10.1167/iovs.06-0361 DO - 10.1167/iovs.06-0361 ID - Lamoureux2007 ER - TY - JOUR AU - Kroenke, K. AU - Spitzer, R. L. AU - Williams, J. B. PY - 2001 DA - 2001// TI - The PHQ-9: validity of a brief depression severity measure JO - J Gen Intern Med VL - 16 UR - https://doi.org/10.1046/j.1525-1497.2001.016009606.x DO - 10.1046/j.1525-1497.2001.016009606.x ID - Kroenke2001 ER - TY - JOUR AU - Yesavage, J. A. AU - Brink, T. L. AU - Rose, T. L. AU - Lum, O. AU - Huang, V. AU - Adey, M. PY - 1982 DA - 1982// TI - Development and validation of a geriatric depression screening scale: a preliminary report JO - J Psychiatr Res VL - 17 UR - https://doi.org/10.1016/0022-3956(82)90033-4 DO - 10.1016/0022-3956(82)90033-4 ID - Yesavage1982 ER - TY - JOUR AU - Zigmond, A. S. AU - Snaith, R. P. PY - 1983 DA - 1983// TI - The hospital anxiety and depression scale JO - Acta Psychiatr Scand VL - 67 UR - https://doi.org/10.1111/j.1600-0447.1983.tb09716.x DO - 10.1111/j.1600-0447.1983.tb09716.x ID - Zigmond1983 ER - TY - CHAP AU - Weiss, D. S. AU - Marmar, C. R. PY - 1997 DA - 1997// TI - The Impact of Event Scale—Revised BT - Assessing psychological trauma and PTSD PB - Guilford Press CY - New York ID - Weiss1997 ER - TY - JOUR AU - Campbell, R. J. AU - Bronskill, S. E. AU - Bell, C. M. AU - Paterson, J. M. AU - Whitehead, M. AU - Gill, S. S. PY - 2010 DA - 2010// TI - Rapid expansion of intravitreal drug injection procedures, 2000 to 2008: a population-based analysis JO - Arch Ophthalmol VL - 128 UR - https://doi.org/10.1001/archophthalmol.2010.19 DO - 10.1001/archophthalmol.2010.19 ID - Campbell2010 ER - TY - JOUR AU - Hanemoto, T. AU - Hikichi, Y. AU - Kikuchi, N. AU - Kozawa, T. PY - 2017 DA - 2017// TI - The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting JO - PLoS One VL - 12 UR - https://doi.org/10.1371/journal.pone.0189035 DO - 10.1371/journal.pone.0189035 ID - Hanemoto2017 ER - TY - JOUR AU - Windsor, M. A. AU - Sun, S. J. J. AU - Frick, K. D. AU - Swanson, E. A. AU - Rosenfeld, P. J. AU - Huang, D. PY - 2018 DA - 2018// TI - Estimating public and patient savings from basic research-a study of optical coherence tomography in managing Antiangiogenic therapy JO - Am J Ophthalmol VL - 185 UR - https://doi.org/10.1016/j.ajo.2017.09.027 DO - 10.1016/j.ajo.2017.09.027 ID - Windsor2018 ER - TY - STD TI - Fabiano G, Russo S, Marcellusi A, Cerri L, Ricci F, Mennini F. OP70 economic impact of macular edema diseases, a retrospective study. Int J Technol Assess Health Care. 2018;33. ID - ref44 ER - TY - JOUR AU - Matamoros, E. AU - Maurel, F. AU - Leon, N. AU - Solomiac, A. AU - Bardoulat, I. AU - Joubert, M. PY - 2015 DA - 2015// TI - Quality of life in patients suffering from active exudative age-related macular degeneration: the EQUADE study JO - Ophthalmologica. VL - 234 UR - https://doi.org/10.1159/000433448 DO - 10.1159/000433448 ID - Matamoros2015 ER - TY - JOUR AU - Shalaby, A. K. AU - Lewis, K. AU - Bush, K. AU - Meredith, P. R. AU - Simplicio, S. AU - Lockwood, A. J. PY - 2016 DA - 2016// TI - Licence to save: a UK survey of anti-VEGF use for the eye in 2015 JO - Eye (Lond) VL - 30 UR - https://doi.org/10.1038/eye.2016.154 DO - 10.1038/eye.2016.154 ID - Shalaby2016 ER - TY - JOUR AU - Schmidt-Erfurth, U. AU - Chong, V. AU - Loewenstein, A. AU - Larsen, M. AU - Souied, E. AU - Schlingemann, R. PY - 2014 DA - 2014// TI - Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA) JO - Br J Ophthalmol VL - 98 UR - https://doi.org/10.1136/bjophthalmol-2014-305702 DO - 10.1136/bjophthalmol-2014-305702 ID - Schmidt-Erfurth2014 ER - TY - JOUR AU - Kume, A. AU - Ohshiro, T. AU - Sakurada, Y. AU - Kikushima, W. AU - Yoneyama, S. AU - Kashiwagi, K. PY - 2016 DA - 2016// TI - Treatment patterns and health care costs for age-related macular degeneration in Japan: an analysis of National Insurance Claims Data JO - Ophthalmology. VL - 123 UR - https://doi.org/10.1016/j.ophtha.2016.01.042 DO - 10.1016/j.ophtha.2016.01.042 ID - Kume2016 ER - TY - JOUR AU - Day, S. AU - Acquah, K. AU - Lee, P. P. AU - Mruthyunjaya, P. AU - Sloan, F. A. PY - 2011 DA - 2011// TI - Medicare costs for neovascular age-related macular degeneration, 1994-2007 JO - Am J Ophthalmol VL - 152 UR - https://doi.org/10.1016/j.ajo.2011.05.008 DO - 10.1016/j.ajo.2011.05.008 ID - Day2011 ER - TY - JOUR AU - Qualls, L. G. AU - Hammill, B. G. AU - Wang, F. AU - Lad, E. M. AU - Schulman, K. A. AU - Cousins, S. W. PY - 2013 DA - 2013// TI - Costs of newly diagnosed neovascular age-related macular degeneration among medicare beneficiaries, 2004-2008 JO - Retina. VL - 33 UR - https://doi.org/10.1097/IAE.0b013e31826f065e DO - 10.1097/IAE.0b013e31826f065e ID - Qualls2013 ER - TY - JOUR AU - Coleman, A. L. AU - Yu, F. PY - 2008 DA - 2008// TI - Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999 JO - Ophthalmology. VL - 115 UR - https://doi.org/10.1016/j.ophtha.2007.04.016 DO - 10.1016/j.ophtha.2007.04.016 ID - Coleman2008 ER - TY - JOUR AU - Rosenfeld, P. J. AU - Windsor, M. A. AU - Feuer, W. J. AU - Sun, S. J. J. AU - Frick, K. D. AU - Swanson, E. A. PY - 2018 DA - 2018// TI - Estimating Medicare and patient savings from the use of Bevacizumab for the treatment of exudative age-related macular degeneration JO - Am J Ophthalmol VL - 191 UR - https://doi.org/10.1016/j.ajo.2018.04.008 DO - 10.1016/j.ajo.2018.04.008 ID - Rosenfeld2018 ER - TY - JOUR AU - Kiss, S. R. AU - Ruiz, Y. AU - Quezada, C. AU - Kathleen, W. AU - Alice, H. AU - Smith David, M. AU - Helen, V. AU - Johnston Stephen, S. PY - 2016 DA - 2016// TI - Real-world treatment patterns in injection cost and frequency for ranibizumab versus aflibercept in patients with wet age-related macular degeneration: A 2-year US claims analysis JO - Invest Ophthalmol Vis Sci VL - 57 ID - Kiss2016 ER - TY - STD TI - Brynskov T, Munch IC, Larsen TM, Erngaard L, Sorensen TL. Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration. Acta Ophthalmol. 2019. ID - ref54 ER -